New Synthetix Improvement Proposal: SIP-423 has been proposed to retire legacy sUSD and reform 420 Pool Staking Summary: SIP-423 proposes retiring legacy sUSD, restructuring the Debt Jubilee, and reforming SNX staking to establish a sustainable long-term foundation for Synthetix. SIP-423 achieves two primary outcomes: 🔹Sunsetting of sUSD on Ethereum mainnet and Optimism. sUSD will be wound down and converted to newly minted SNX on Ethereum Mainnet 🔹Restructuring of the 420 Pool Debt Jubilee and SNX staking Please visit the official Synthetix SIPs site at the link below to view all details concerning SIP-423, including the voting timeline and all planned changes: 🔗 sips.synthetix.io/sips/sip-4… For all discussions & queries relating to SIP-423, please head to the official Synthetix Discord: discord.gg/synthetix

SpaceX is the most overhyped IPO of the decade and it will end exactly the way every overhyped IPO ends. Facebook IPO’d at $38 and traded under that for 15 months. Uber IPO’d at $45 and is still below that adjusted seven years later for a while. WeWork tried at $47 billion and ended at zero. Robinhood IPO’d at $38, hit $85, then $7. Coinbase IPO’d at $381 and was at $40 two years later. Rivian IPO’d at a $100 billion valuation with no meaningful revenue and gave back 90%. Beyond Meat. Peloton. Lyft. DoorDash. Bird. Each one a “generational company” the day it priced. Each one a wealth destruction event for retail within 18 months. The pattern is not a coincidence. Hype IPOs are designed to transfer wealth from the people buying the story to the people who built the story. The bankers get paid. The early employees get out. The VCs get a markup they can show their LPs. The retail investor gets the bag. SpaceX is a great company. That has nothing to do with whether it’s a great stock at IPO. Greatness was already priced in five funding rounds ago. You are not getting in early. You are buying the exit. The only IPO worth chasing is the one nobody is talking about. Those don’t exist anymore because every IPO is marketed like a movie release. So the answer is: don’t chase. Wait two years. Buy it down 70% when the lockup unwinds and the narrative breaks. Or don’t buy it at all and put the money somewhere the bankers haven’t already extracted the alpha. Hype is not an asset class. It’s a tax.

Introducing Llamalend v2 A new lending framework built around Curve liquidity - Use Curve LP tokens as collateral - Isolated market risk - Improved range-based liquidations powered by LLAMMA - Better market security Launching first on Optimism. news.curve.finance/introduci…

If you buy any amount of Bitcoin now, your savings will DOUBLE when Bitcoin goes back to its all time high $1,000 will turn into $2,000 "But $1,000 won't change my life" You don't just have to buy $1,000 worth You can scale up to any amount If you buy $10,000 worth, you will be up $10,000 when Bitcoin is at $126K $100,000 -> $200,000 $1,000,000 -> $2,000,000 $126K is inevitable, it's just a matter of time

SpaceX is trading today at 4.2% of the company total issued shares. The other 95.8% unlocks on a schedule most people haven't read: • Aug 5: 20% of insider shares eligible (Q2 earnings) • Aug–Oct: 7% every ~2 weeks, five times • Nov 4: 28% • Jun 13, 2027 Musk's 42%, all at once And one clause almost nobody noticed: if the stock holds 30% over IPO, extra shares unlock EARLY. The rally speeds up the supply. Every one of these dates will be a headline. You can read the 300-page S-1, or see it on one page, free, no signup: tokenomist.ai/stock/spcx (Unlocked ≠ sold. But you can't read this stock without the calendar.)

I am sorry to point it out but these fees are only the gross interest paid by borrowers Need to apply Aave reserve factor to get revenues: currently $100m annualized with a P/S < 10x. Probably still cheap. Adobe is trading at 13x...

Euler Monad TVL increased by 50% over the last month. gMonad

fun fact: charles hoskinson's private jet ranked top 15 in 2022 for carbon emissions

Very important point: SoftBank was pledging *all* of its OpenAI stock (worth $60bn on paper) to get a $6 billion margin loan. Banks turned it down due to concerns about the value of OpenAI stock. Banks clearly do not think OpenAI is worth $852 billion. tradingkey.com/analysis/stoc…

Morpho Association has raised $175M to build the open credit network for the world. Co-led by @paradigm, @a16zcrypto, @RibbitCapital with strategic participation from @apolloglobal, @vaneck_us, @circle_ventures, and @Ledger @Cathayinnov. The round also included participation from @variantfund, @wmt_ventures, @preludexyz, @IOSGVC, @HashKey_Capital, @sbigroup, @Bpifrance, @mirana, @bamazizimesh, NJJ Capital and 10 other strategic partners. The funding will help accelerate Morpho's position as the foundation for onchain credit.

in coding and mathematics, the verifier is fast. in chemistry and biology, the verifier is the world. a model can propose ten thousand candidate molecules quickly. testing one means synthesizing it, running an assay and then waiting weeks or even years. bio databases will be solved. we need to close the loop between what the model proposes and what the world confirms with autonomous labs, robotic synthesis and real-time experimental feedback.

After the unexpected engagement on my post yesterday, I felt some responsibility to dig into the new ticker about to come from ex-Aave team. Firstly, there is clearly something being built at BGD Labs by looking the signs of their bios and posts. It's also clear that people from ACI seem to support them too again based on their reposts. So, it's almost guaranteed that ACI and BGD Labs will move together, not separately. That's why I believed it is important to keep an eye on. A completely new ticker was only a one possibility. I know what many of you think. So, let's kill the elephant in the room: Are they planning to join Euler Finance @eulerfinance under ticker $EUL?

Imagine you had the energy, metabolism, and mental agility of your younger self - without the aches and pains that come from aging. That’s what we’re attempting to build at @NewLimit and it will be one of the most important achievements in human history ever if it works. We're on the cusp of this being tractable given the rise of AI to test more hypotheses in-silico, along with the rapidly falling cost of single cell sequencing, etc. We announced our Series C and upcoming human clinical trials this week, so still a long, long way to go, with many risks. But with hard work we've got a shot at making this a reality.

Remember what Warren Buffett once said: “Never ask a barber if you need a haircut.”

Following the recent post outlining the backing diversification of USDe, we have published the next phase of that work: broadening RWA exposure beyond tokenized T-Bills. The first asset category under evaluation is AAA CLOs, which sit at the top of the capital stack, with a zero default rate at the AAA level across the entire history of the asset class. The allocation helps diversify the sources of revenue for Ethena across market cycles. Our first partnerships and allocations with asset managers and issuers in this category will be released next week. Details in the link below: